3M™ Topical Tissue Adhesive Versus Commercially Available Tissue Adhesive for the Closure of Lacerations and Incisions

Inclusion Criteria: * Subject is at least 22 years of age on the date of informed consent * Subject or Subject's legally authorized representative can provide informed consent * Subject is willing and able to attend all scheduled study visits and abide by all study restrictions * Subject has a single laceration that is ≤ 100 mm (10.0 cm) in length or up to 4 surgical incision(s), each ≤ 100 mm (10.0 cm) in length, defined as Class I or Class II wound(s), in which the use of a tissue adhesive (in combination with but not replacing deep dermal sutures, if applicable) is appropriate, including the following: * surgical incision from a minimally invasive surgery * low tension incision * superficial laceration * clean, traumatic laceration with edges that can be easily approximated Exclusion Criteria: * Subject has a positive pregnancy test within 48 hours prior to randomization at Day 0 or is lactating prior to randomization at Day 0 * Subject is found to have any of the following before randomization: * a known peripheral vascular disease * a history of hypertrophic scarring and/or keloids * any Class III or Class IV wounds * uncontrolled diabetes mellitus (DM), defined as HbA1C ≥ 10% within 90 days before screening. If HbA1C data is unavailable or the Subject presents in an emergency situation, uncontrolled DM will be defined as blood glucose ≥ 250 mg/dL * a known blood clotting disorder * immunocompromised * a known systemic or local bacterial, viral…